Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Chahrazade Kantari-Mimoun, Ewelina Krzywinska, Magali Castells, Corinne Milien, Ralph Klose, Anna-Katharina Meinecke, Ursula Lemberger, Thomas Mathivet, Milos Gojkovic, Katrin Schrödter, Christoph Österreicher, Joachim Fandrey, Helene Rundqvist, Christian Stockmann
Published Jan 19, 2017 · Vol. 8, No. 9 · pp. 15085-15100
Alison Roos, Harshil D. Dhruv, Ian T. Mathews, Landon J. Inge, Serdar Tuncali, Lauren K. Hartman, Donald Chow, Nghia Millard, Holly H. Yin, Jean Kloss, Joseph C. Loftus, Jeffrey A. Winkles, Michael E. Berens, Nhan L. Tran
Published Jan 17, 2017 · Vol. 8, No. 7 · pp. 12234-12246
Zhi Hong Lu, Sergey Kaliberov, Rebecca E. Sohn, Lyudmila Kaliberova, Yingqiu Du, Julie L. Prior, Daniel J. Leib, Anne Chauchereau, Jennifer K. Sehn, David T. Curiel, Jeffrey M. Arbeit
Published Jan 17, 2017 · Vol. 8, No. 7 · pp. 12272-12289